07:00 , Jun 9, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Gastrointestinal disease

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Gastrointestinal disease Colitis Epidermal growth factor receptor (EGFR); Lactobacillus rhamnosus GG p40 surface antigen (p40) Mouse studies suggest L. rhamnosus p40...